Akers Biosciences, Inc. Gains 29.07%
Thu, Nov 12, 2020 at 05:30 PM
Akers Biosciences, Inc. (AKER:NASDAQ) rocketted at $2.22, representing a gain of 29.1%. On Wed 11 Nov 20, AKER:NASDAQ hit a New 2-Week Intraday Low of $1.65. The stock got featured on our News Catalysts scanner on Thu 12 Nov 20 at 05:21 PM in the 'ACQUISITION' category. From Wed 28 Oct 20, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Mon 10 Aug 20 at $6.97 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Akers Biosciences, Inc. (AKER:NASDAQ)
Akers Biosciences Inc is engaged in the development and sale of disposable diagnostic testing device. The Company develops, manufactures, and supplies rapid, point-of-care screening and testing products.
Top 10 Gainers:
- IMAC Holdings, Inc. (IMAC:NASDAQ), 83.29%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 67.23%
- EuroDry Ltd. (EDRY:NASDAQ), 58.13%
- Pyxis Tankers Inc. (PXS:NASDAQ), 40.64%
- XPEV (XPEV:NYSE), 33.4%
- Akers Biosciences, Inc. (AKER:NASDAQ), 29.07%
- Celsius Holdings, Inc. (CELH:NASDAQ), 29.03%
- Electrameccanica Vehicles Corp. (SOLO:NASDAQ), 28.12%
- LI (LI:NASDAQ), 27.27%
- Biocept, Inc. (BIOC:NASDAQ), 24.95%